Last reviewed · How we verify
Respiratory tract infection
Approved treatments
- Gracevit · Daiichi Sankyo
- Azidobenzylpenicillin
Azidocillin works by inhibiting the synthesis of the bacterial cell wall, ultimately leading to bacterial death. - Faropenem Daloxate
Faropenem Daloxate works by inhibiting bacterial cell wall synthesis. - Fropenem
Faropenem works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Respiratory tract infection patent landscape — cliff calendar, originator estates, attackable patents
- Respiratory tract infection treatment landscape brief
- Respiratory tract infection treatment updates RSS
Frequently asked questions about Respiratory tract infection
What drugs treat Respiratory tract infection?
Tracked treatments include Gracevit, Azidobenzylpenicillin, Faropenem Daloxate, Fropenem.
What is the treatment for Respiratory tract infection?
Standard treatment for Respiratory tract infection includes Gracevit, Azidobenzylpenicillin, Faropenem Daloxate, Fropenem. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Respiratory tract infection patent cliff · Respiratory tract infection CI report
- Treatment: Gracevit · Daiichi Sankyo
- Treatment: Azidobenzylpenicillin
- Treatment: Faropenem Daloxate
- Treatment: Fropenem
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing